Can You Proceed with Thoracotomy at INR 1.9?
No, you should not proceed with thoracotomy at INR 1.9 - this level is too high for a high-bleeding-risk procedure like thoracotomy and requires correction before surgery.
Risk Stratification
Thoracotomy is definitively a high bleeding risk procedure (≥2% risk of major bleeding within 30 days). According to current perioperative guidelines, procedures with high bleeding risk require complete interruption of anticoagulation with minimal residual drug effect 1.
INR Threshold Analysis
The evidence clearly demonstrates a dose-response relationship between elevated INR and bleeding complications:
- INR >1.5: Multiple studies show significantly increased bleeding risk at this threshold 2, 3, 4
- INR 1.25-1.5: 2.4-2.5 times higher odds of postoperative bleeding requiring transfusion 3, 4
- INR >1.0-1.25: 1.6-1.7 times higher odds of bleeding complications 3, 4
Your patient's INR of 1.9 falls well above the concerning threshold of 1.5, placing them at substantially elevated risk for major bleeding during and after thoracotomy.
Management Algorithm
For warfarin-treated patients requiring high-bleeding-risk surgery:
- Withhold warfarin 5-6 days before surgery 1
- Check INR 1-2 days preoperatively
- If INR >1.5 on day before surgery: Consider 1 mg oral vitamin K, which normalizes INR (≤1.3) in 76.6% of patients by surgery day 5
- Target INR: Should be ≤1.3 for high-bleeding-risk procedures
Critical Caveats
- The 2022 CHEST guidelines suggest against routine vitamin K for INR >1.5 preoperatively 6, but this recommendation carries very low certainty of evidence and applies to general elective surgery
- For high-bleeding-risk procedures specifically (like thoracotomy), the risk-benefit calculation shifts dramatically toward correction
- One study showing safety of thoracentesis at elevated INR 7 is not applicable - thoracentesis is a minimally invasive needle procedure, fundamentally different from open thoracotomy
Bridging Considerations
If your patient has high thrombotic risk (mechanical mitral valve, recent VTE <3 months, CHA₂DS₂-VASc ≥7), consider bridging with parenteral heparin once INR drops below therapeutic range 1. However, do not proceed with surgery until INR is adequately corrected.
Bottom line: Delay surgery, correct the INR to ≤1.3-1.5, then proceed. The mortality risk from intraoperative or postoperative hemorrhage during thoracotomy at INR 1.9 outweighs the thrombotic risk of brief anticoagulation interruption in virtually all clinical scenarios.